跳至主要内容
临床试验/NCT04971889
NCT04971889进行中(未招募)不适用

Diabetes Medical Nutrition Therapy in Southeastern African American Women

Meharry Medical College2 个研究点 分布在 1 个国家目标入组 291 人开始时间: 2021年8月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
291
试验地点
2
主要终点
HbA1c

研究概览

简要总结

A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •African American
  • •Clinical diagnosis of type 2 diabetes for at least 6 months
  • •At risk for development and/or progression of diabetes complications (HbA1c ≥ 7.0% AND either systolic blood pressure ≥130, LDL cholesterol ≥ 100, or BMI ≥ 30).

排除标准

  • •-Observed or diagnosed psychotic disorders

研究组 & 干预措施

Diabetes MNT plus MI

Active Comparator

--Group-based dietary/dietary motivation intervention

干预措施: Diabetes MNT (Behavioral)

Diabetes MNT plus MI

Active Comparator

--Group-based dietary/dietary motivation intervention

干预措施: Motivational Interviewing (Behavioral)

Diabetes MNT

Active Comparator

-Group-based dietary intervention

干预措施: Diabetes MNT (Behavioral)

结局指标

主要结局

HbA1c

时间窗: Baseline

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Change from Baseline HbA1c

时间窗: 12 months

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Change from Baseline HbA1c

时间窗: 3 months

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Change from Baseline HbA1c

时间窗: 6 months

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

次要结局

  • LDL Cholesterol(Baseline)
  • Systolic Blood Pressure(Baseline)
  • Body Mass Index(Baseline)
  • Change from baseline LDL Cholesterol(12 months)
  • Change from Baseline Body Mass Index(12 months)
  • Change from baseline Systolic Blood Pressure(12 months)
  • Change from Baseline Body Mass Index(3 months)
  • Change from Baseline Body Mass Index(6 months)
  • Change from baseline LDL Cholesterol(3 months)
  • Change from baseline LDL Cholesterol(6 months)
  • Change from baseline Systolic Blood Pressure(3 months)
  • Change from baseline Systolic Blood Pressure(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephania T. Miller-Hughes

Professor

Meharry Medical College

研究点 (2)

Loading locations...

相似试验